These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27282415)

  • 1. Doxorubicin-induced co-assembling nanomedicines with temperature-sensitive acidic polymer and their in-situ-forming hydrogels for intratumoral administration.
    Wan J; Geng S; Zhao H; Peng X; Zhou Q; Li H; He M; Zhao Y; Yang X; Xu H
    J Control Release; 2016 Aug; 235():328-336. PubMed ID: 27282415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
    Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
    J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulation of Thermo-responsive Gel in pH-sensitive Polymersomes as Dual-Responsive Smart carriers for Controlled Release of Doxorubicin.
    Oroojalian F; Babaei M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M
    J Control Release; 2018 Oct; 288():45-61. PubMed ID: 30171978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
    Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
    J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery.
    Hou J; Guo C; Shi Y; Liu E; Dong W; Yu B; Liu S; Gong J
    Int J Pharm; 2017 Nov; 533(1):73-83. PubMed ID: 28943209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
    Ren S; Dai Y; Li C; Qiu Z; Wang X; Tian F; Zhou S; Liu Q; Xing H; Lu Y; Chen X; Li N
    Eur J Pharm Sci; 2016 Sep; 92():137-45. PubMed ID: 27388491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
    Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
    J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic anti-tumor activity through combinational intratumoral injection of an in-situ injectable drug depot.
    Kim DY; Kwon DY; Kwon JS; Park JH; Park SH; Oh HJ; Kim JH; Min BH; Park K; Kim MS
    Biomaterials; 2016 Apr; 85():232-45. PubMed ID: 26874285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel drug delivery system using thermoreversible gelation polymer for malignant glioma.
    Arai T; Joki T; Akiyama M; Agawa M; Mori Y; Yoshioka H; Abe T
    J Neurooncol; 2006 Mar; 77(1):9-15. PubMed ID: 16292493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of doxorubicin and (131)I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy.
    Huang P; Zhang Y; Wang W; Zhou J; Sun Y; Liu J; Kong D; Liu J; Dong A
    J Control Release; 2015 Dec; 220(Pt A):456-464. PubMed ID: 26562684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo.
    Gu X; Wei Y; Fan Q; Sun H; Cheng R; Zhong Z; Deng C
    J Control Release; 2019 May; 301():110-118. PubMed ID: 30898610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy.
    Zou Y; Fang Y; Meng H; Meng F; Deng C; Zhang J; Zhong Z
    J Control Release; 2016 Dec; 244(Pt B):326-335. PubMed ID: 27245309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer.
    Kang YM; Kim GH; Kim JI; Kim DY; Lee BN; Yoon SM; Kim JH; Kim MS
    Biomaterials; 2011 Jul; 32(20):4556-64. PubMed ID: 21440935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable in Situ Forming Hydrogels of Thermosensitive Polypyrrole Nanoplatforms for Precisely Synergistic Photothermo-Chemotherapy.
    Geng S; Zhao H; Zhan G; Zhao Y; Yang X
    ACS Appl Mater Interfaces; 2020 Feb; 12(7):7995-8005. PubMed ID: 32013384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.
    Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y
    Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
    Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacokinetics, biodistribution and the anti-tumor effect of cyclic RGD-modified doxorubicin-loaded polymers in tumor-bearing mice.
    Wang C; Li Y; Chen B; Zou M
    Colloids Surf B Biointerfaces; 2016 Oct; 146():31-8. PubMed ID: 27244048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.